Ophthalmology · Miami, FL
NPI
1174530323
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
900 NW 17th St, Box 025809
Miami, FL, 33136
Phone (305) 326-6340
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.3M
56,294 services
Medicare patients, 2024
1,717
Average age 79
Drug cost, 2024
$99K
805 prescriptions
Company payments, 2025
$96K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jaclyn Kovach was code J2777 (injection, faricimab-svoa, 0.1 mg), 43,080 times for 129 patients. In total Jaclyn Kovach billed 56,294 services in 35 codes, and Medicare paid $3.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 43,080 | 129 | $27.56 | $1.2M |
| 92134 Computerized Ophthalmic Imaging | Office | 2,705 | 1,073 | $29.61 | $80K |
| 67028 Intravitreal Injection | Office | 1,601 | 393 | $97.60 | $156K |
| 99214 Office E&M - Established | Office | 1,571 | 754 | $94.50 | $148K |
| 92014 Ophthalmological E&M | Office | 1,459 | 977 | $85.14 | $124K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,390 | 167 | $657.84 | $914K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 1,170 | 42 | $263.83 | $309K |
| 92250 Angiography | Office | 797 | 613 | $25.58 | $20K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 540 | 13 | $86.19 | $47K |
| J2778 Injection, ranibizumab, 0.1 mg | Office | 530 | 23 | $126.19 | $67K |
| J3490 Unclassified drugs | Office | 297 | 92 | $371.60 | $110K |
| 99204 Office E&M - New | Office | 151 | 151 | $112.43 | $17K |
| 92133 Computerized Ophthalmic Imaging | Office | 107 | 97 | $24.76 | $2,649 |
| 92004 Ophthalmological E&M | Office | 94 | 94 | $95.67 | $8,993 |
| 76512 Ultrasound - Nonspecific | Office | 60 | 50 | $32.35 | $1,941 |
By year: 2022 $2.9M for 15,677 services; 2023 $3.1M for 46,484 services; 2024 $3.3M for 56,294 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jaclyn Kovach prescribed most often to Medicare patients was Latanoprost, with 139 prescriptions and refills. In total Jaclyn Kovach wrote 805 Medicare prescriptions that cost $99K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 139 | 313 | 38 | $1,728 |
| Prednisolone Acetate Generic | 110 | 145 | 55 | $3,352 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 92 | 195 | 24 | $1,469 |
| Timolol Maleate Generic | 85 | 170 | 23 | $1,818 |
| Ketorolac Tromethamine Generic | 54 | 72 | 17 | $1,207 |
| Travoprost Generic | 39 | 65 | 11 | $5,823 |
| Erythromycin Erythromycin Base | 36 | 45 | 16 | $859 |
| Dorzolamide Hcl Generic | 35 | 68 | 11 | $456 |
| Restasis Cyclosporine | 26 | 46 | Under 11 | $24K |
| Brimonidine Tartrate Generic | 24 | 48 | Under 11 | $4,839 |
| Nevanac Nepafenac | 18 | 27 | Under 11 | $16K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 17 | 30 | Under 11 | $2,960 |
| Fluorometholone Generic | 14 | 32 | Under 11 | $1,789 |
Brand drugs: 284 claims; generic drugs: 521 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jaclyn Kovach $96K ($95K in general payments such as food, travel and fees and $929 for research) from 7 companies. The largest payer was Apellis Pharmaceuticals, Inc. with $60K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.